USPH Q2 GAAP EPS falls to $0.25 from $0.58; revenue up 8.5%; reaffirms FY guidance

U S PHYSICAL THERAPY INC /NV

Q2 2026 net revenue $214.1M (+8.5% YoY); GAAP EPS $0.25 vs $0.58; adjusted EBITDA $27.0M vs $26.9M.
Physical therapy net revenue $182.4M (+8.4%); visits up 6.6%; net revenue per visit $107.59 (+$2.26).
Board declared $0.46 quarterly dividend, payable Sept 11, 2026 to holders of record Aug 21.
Three 2026 acquisitions totaling $37.6M; July 1 added 12 clinics for $16.4M.
Full-year 2026 adjusted EBITDA guidance reaffirmed at $102M-$106M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.